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In cirrhotic patients, in addition to hepatocytes and Kuppfer cells dysfunction circulatory anatomic shunt and 
ventilation/perfusion (VA/ Q) ratio abnormalities can induce decrease in partial pressure of oxygen in arterial 
blood (PaO2), in oxygen saturation of hemoglobin (SaO2) as well as various acid-base disturbances. We studied 49 
cases of liver cirrhosis (LC) with ascites compared to 50 normal controls. Causes were: posthepatic 37 (75.51%), 
alcoholic 7 (14.24%), cardiac 2 (4.08%), and cryptogenic 3 (6.12%). Complications were: upper gastrointestinal 
bleeding 24 (48.97), hepatic encephalopathy 20 (40.81%), gastritis 28 (57.14%), hepatoma 5 (10.2%), renal hepatic 
syndrome 2 (4.01%), HbsAg (+) 24 (48.97%), and hepatic pleural effusions 7 (14.28%). Average PaO2 and SaO2 
were 75.2 mmHg and 94.5 mmHg, respectively, compared to 94.2 mmHg and 97.1 mmHg of the control group, 
respectively (p value in both PaO2 and SaO2 was p<0.01). Respiratory alkalosis, metabolic alkalosis, metabolic 
acidosis, respiratory acidosis and metabolic acidosis with respiratory alkalosis were acid-base disturbances ob-
served. In conclusion, portopulmonary shunt, intrapulmonary arteriovenous shunt and VA/Q inequality can 
induce a decrease in PaO2 and SaO2 as well as various acid-base disturbances. As a result, pulmonary resistance is 
impaired and patients more likely succumb to infections and adult respiratory distress syndrome. 
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1.  Introduction 
The arterial blood of some patients with cirrhosis 
is not fully saturated with oxygen, probably as a result 
of an admixture of venous with arterial blood and 
under- ventilation of some alveoli [1]. There are well 
known right-to-left anatomic shunts demonstrable 
between vessels that carry venous blood and those that 
carry oxygenated blood in the lungs. Arteriovenous 
shunt may be congenital e.g. in hereditary hemor-
rhagic teleangiectasia (Rendu Osler Weber disease) 
where the lesion is transmitted as a simple 
non-sex-linked dominant and the disorder is observed 
in the lungs as single or multiple lesions, or may be 
acquired [2]. Intrapulmonary arteriovenous shunt and 
portopulmonary shunt may be acquirely observed in 
patients with chronic liver disease [3, 4, 5, 6]. 
Hepatopulmonary syndrome refers to the triad of 
liver disease, pulmonary vascular dilation, and re-
duced arterial oxygenation [7]. While marked mani-
festations of the syndrome are unusual in patients with 
chronic liver disease, more subtle abnormalities of 
oxygenation are common. The abnormalities have 
been attributed to right-to-left shunts through pul-
monary arteriovenous fistulas and development of 
bronchial varices in association with pulmonary hy-
pertension. The syndrome occurs in chronic liver dis-
ease of all types and is more common in those with 
severe liver disease. Furthermore, portopulmonary 
shunt is another mechanism inducing blood gas al-
terations observed in patients suffering from severe 
chronic liver cirrhosis with ascites [8]. It is well known 
that portal hypertension has an important role in the 
formation of ascites by raising hydrostatic pressure 
within the splanchnic capillary bed. Ascites is most 
frequently encountered in patients with cirrhosis and 
other forms of severe liver disease. The clinical course 
of patients with advanced cirrhosis is often compli-
cated by a number of important sequelae that are in-
dependent of the etiology of the underlying liver dis-
ease. These include portal hypertension with its con-
sequences (e.g. gastroesophageal varices and 
splenomegaly), ascites, hepatic encephalopathy, 
spontaneous bacterial peritonitis, hepatorenal syn-
drome, hepatopulmonary syndrome, hepatocellular 
carcinoma as well as some other sequelae. In some 
patients with massive ascites, pleural effusion is Int. J. Med. Sci. 2007, 4 
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common but even without it, pulmonary collapse and 
atelectasis may lead to arterial undersaturation since 
some alveoli are underventilated or not ventilated at 
all. 
As a result of all those above described abnor-
malities the prognosis is poor on the basis of both the 
pulmonary and hepatic disease in patients with severe 
liver cirrhosis and ascites. 
2.  Methodology 
Forty-nine (49) patients without any cardiopul-
monary disease with liver cirrhosis and ascites (35 
males, 14 females, ratio 2.5:1 and average mean age 65 
years with age range 42-81 years) were enrolled in the 
study. A group of fifty (50) healthy individuals con-
sisted the control group. Cirrhosis had been diagnosed 
by history, clinical examination, laboratory findings, 
and liver biopsy, which all patients underwent. From a 
clinical point of view the patients’ conditions varied 
from moderate to severe according to the Child-Pugh 
classification (B, C class). None of the patients com-
plained of dyspnea. Patients with parenchymal lung 
disease were excluded from the study. Furthermore, 
none of them presented diagnostic criteria for asthma, 
chronic bronchitis, or emphysema according to the 
American Thoracic Society Directions. 
Since classification of the various types of cirrho-
sis based on either etiology or morphology alone is 
unsatisfactory, we usefully classified the studied pa-
tients by a mixture of etiologically and morphologi-
cally defined entities based on clinical, pathological, 
and other data as follows: posthepatic 37 cases 
(75.51%), alcoholic 7 cases (14.24%), cardiac 2 cases 
(4.08%), and cryptogenic 3 cases (6.12%). The term 
posthepatic, synonymously to postnecrotic or multi-
lobular cirrhosis, has been used in cases of cirrhosis 
resultant to viral hepatitis or infectious diseases, 
autoimmune hepatitis, inherited and metabolic disor-
ders, as well as to drugs and toxins. In particular, 
based on epidemiologic and serologic evidence 
(HBsAg, HBeAg, anti-HbC, HBV-DNA) the vast ma-
jority of posthepatic cases was due to viral hepatitis (35 
cases, 94.59%), due mostly to type B (26 cases, 74.28%), 
or type C (7cases, 20%), and concomitant presence in 2 
cases (5.71%). Similarly, the term cryptogenic cirrhosis 
has been used in cases in which the etiology of the 
cirrhosis was unknown. 
Complications observed in the patients studied 
were: upper gastrointestinal (UGI) bleeding in 20 cases 
(48.97%), hepatic encephalopathy 20 cases (40.81%), 
gastritis 28 cases (57.14%), hepatoma 5 cases (10.2%), 
hepatorenal syndrome 2 cases (4.01%), HbsAg (+) 24 
cases (48.97%), and hepatic pleural effusions 7 cases 
(14.28%). Table 1 and table 2 summarize patients clas-
sification and complications observed. 
Partial pressure of oxygen in arterial blood (PaO2), 
oxygen saturation of hemoglobin (SaO2) as well as 
various acid-base disturbances were determined in all 
patients and normal controls as well. Arterial blood 
samples were taken while patients were breathing 
room air (FiO2: 21%) in a half seated position. They 
underwent a puncture from the radical artery. PaO2 
was immediately measured as well as carbon dioxide 
tension (PaCO2) and oxyhemoglobin saturation (SaO2).  
Table 1. Classification of patients of the study. 
Etiology of the disease  Nr % 
posthepatic 37  75.51 
alcoholic 7  14.24 
cardiac 2  4.08 
cryptogenic 3  6.12 
Total 49  100 
Table 2. Complications of the cirrhotic patients under study. 
   Nr  % 
UGI bleeding    24  48.97 
Hepatic encephalopathy  20  40.81 
Gastritis 28  57.14 
Hepatoma 5  10.2 
Hepatorenal syndrome  2  4.01 
Hbs Ag +  24  48.97 
Hepatic pleural effusion  7  14.28 
    
Accompanied acid base disturbances    
Respiratory alkalosis  22  44.89 
Metabolic alkalosis  7  14.28 
Metabolic acidosis  3  6.12 
Respiratory acidosis  3  6.12 
Metabolic acidosis + respiratory alkalosis  4  8.16 
Normal acid base balance  10  20.4 
3.  Results 
A PaO2 of equal or less than 80mmHg was de-
fined as hypoxemia values. Values taken from the pa-
tients group were as low as below 80 mm Hg with an 
average PaO2 of 75.2 mm Hg while that in fifty healthy 
controls was 94.2 mm Hg. 
Statistically, a significant difference was found 
(p<0.01) between those compared groups. SaO2 values 
were in average 94.5 mm Hg and 97.1 mm Hg, respec-
tively, showing also a statistically significant difference 
(p<0.01). Furthermore, a weak relationship between 
PaO2 and Pugh score was found in the patients group. 
Mean arterial PaCO2 in the patients group was 33.9±1.5 
mmHg with hypocapnia most frequently found. 
Acid-base disturbances observed were: respira-
tory alkalosis in 22 cases (44.89 %), metabolic alkalosis 
in 7 (14.28 %), metabolic acidosis in 3 (6.12 %), respi-
ratory acidosis in 3 (6.12 %), and metabolic acidosis 
with respiratory alkalosis in 4 (8.16 %). Normal acid 
base balance was observed in 10 (20.40 %). Breath rate 
frequency in all patients studied, was within the nor-
mal rates; thus, acid-base disturbances could not be 
attributed solely to breath frequency abnormalities (e.g. 
respiratory alkalosis in patients with tachypnea). 
Tables 1 and 2 show the classification of patients 
regarding the etiology of their disease as well as com-
plications and acid based disturbances observed. None 
of the complications observed was attributed to drugs 
administered. 
4.  Discussion 
Mild hypoxemia occurs in approximately 
one-third of patients with chronic liver disease. Arte-Int. J. Med. Sci. 2007, 4 
 
96
rial venous anastomoses and communications between 
the portal and arterial circulation as well as between 
bronchial and pulmonary veins are more likely to be 
functional in patients with cirrhosis and account for 
hypoxemia, as well as for perfusion defects seen on 
lung scan in patients with cirrhosis [9].  
Shunts observed in patients with severe liver 
disease resulting in blood gas alterations may be con-
tributed to portopulmonary shunt due to the portal 
hypertension development as well as to intrapulmon-
ary arteriovenous shunt and VA/Q inequality. Hepa-
topulmonary syndrome, an infrequent complication of 
chronic liver disease usually associated with portal 
hypertension and cirrhosis, is manifested by dyspnea, 
platypnea and orthopnea and nowadays is more 
widely diagnosed occurring in chronic liver disease of 
all types and mainly in severe suffering patients [4, 9, 
10, 11]. 
Liver cirrhosis is often accompanied by arterial 
hypoxemia in the absence of cardiopulmonary disease 
but the natural history of this syndrome is unknown. 
This fact was initially thought to be associated with the 
severity of the liver disease [12]. None of the patients 
enrolled in our study presented dyspnea and/or 
chronic lung disease according to the American Tho-
racic Society Directions. However, spirometric tests 
performed in all patients studied, confirmed the issue 
under discussion. Although putative mechanisms of 
hypoxemia include an intra- or extrapulmonary shunt, 
ventilation – perfusion inequality, and alveolar capil-
lary diffusion limitation, there is a lack of agreement 
on which factors are the most important [13]. To the 
majority of cirrhotic patients that present dyspnea, this 
appears to be a consequence of ascites, hepatic hydro-
thorax or cardiopulmonary diseases. A wide spectrum 
of pulmonary gas exchange abnormalities may be 
found in patients with advanced liver disease [14]. The 
most frequent alteration of gas exchange in cirrhosis is 
hypocapnia observed in approximately 73% of cir-
rhotic patients which is associated with pulmonary 
vasodilatation. We hypothesize that hypocania, in as-
sociation with vasodilating substances such as nitric 
oxide (NO) and endothelins, may contribute- at least in 
part- in the induction of hypoxemia. Pulmonary vaso-
dilatation is even more frequent and severe in patients 
with advanced hepatocellular dysfunction. Intrapul-
monary vasodilatation found in cirrhosis is thought to 
be at least partly involved in the development of hy-
poxemia, though some studies are arguing whether or 
not hypoxemia develops in patients with intrapul-
monary vasodilatation [15, 16]. In our study all of pa-
tients with cirrhosis (Child-Pugh B and C) had hy-
poxemia. 
 Contradictory, according to another study, the 
factor mostly inducing hypoxemia in liver cirrhosis is 
not the disease severity or the abnormal pulmonary 
circulation but rather the alcoholic etiology of cirrhosis 
[16]. Furthermore, according to similar studies the 
smoking status frequently coexisting in alcoholics had 
no significant effect on pulmonary functions in pa-
tients with liver diseases [16, 17]. Hypoxemia observed 
in alcoholic cirrhosis does not seem to be caused by 
alcohol induced disorders in the extrahepatic organs. It 
seems rather to be associated with an accelerated hy-
perdynamic and hypermetabolic circulatory state that 
favors hypoxemia [18, 19]. All patients with alcoholic 
cirrhosis studied, herein, (7 out of 49, 14.24%) were in a 
hypoxemic state. Several studies support this assump-
tion suggesting that an increased oxygen demand due 
to excess alcohol consumption is the primary cause of 
hypoxemia in alcoholic patients [19]. Moreover, in 
these series of patients none presented with dyspnea 
or clinical signs of hepatopulmonary syndrome. These 
findings confirm previous clinical investigations that 
illustrated hypoxemia is a common finding in patients 
with cirrhosis particularly in those with Child-Pugh 
grade C, (grade < 14), in whom, furthermore, clinical 
manifestations were rare [20-23]. According to previ-
ously published studies, concerning patients with liver 
cirrhosis, the incidence of hypoxemia appeared to be 
high in Child-Pugh grade C, presenting a slight dif-
ference with those patients classified as grade A or B 
[12, 23]. Results of the present study coincide with 
these reports published earlier. The weak link between 
PaO2 and Pugh score found herein, suggests that other 
mechanisms apart from PaO2, are involved in the cir-
rhosis associated hypoxemia mechanisms. 
Chronic liver disease, arterial deoxygenation and 
widespread intrapulmonary vasodilatation character-
ize the hepatopulmonary syndrome [22]. In decom-
pensate cirrhotic patients, there is an increased arte-
riovenous shunt for oxygen in the lower extremities 
that is associated with increased arterial blood flow, 
decreased systemic vascular resistance and worsening 
of the liver function. This shunt is due at least partly to 
the opening of arteriovenous precapillary connections 
[24]. No any treatment is clinically useful, thus, at 
present the only treatment resulting to the resolution 
of the syndrome with simultaneous correction of the 
blood gas oxygenation alterations is the orthotopic 
liver transplantation.  
Fluid in the chest (pleurisity) may be found in at 
least 10 percent of patients with cirrhosis, being more 
common on the right side influencing when in large 
quantities the VA/Q ratio. In the present study 7 pa-
tients (14.28%) presented pleurisity. Hypoxemia usu-
ally appears to be worse in standing than in supine 
position. Oxygen administration improves dyspnea 
but does not reverse the defects in some patients [25]. 
Embolization of shunts if it is possible may be useful.  
Gastrointestinal hemorrhage, in the type of 
variceal bleeding represents a common complication 
of chronic liver disease and is associated with a high 
mortality. Studies carried out in a cirrhotic rat model 
suggested that blood volume restitution following 
hemorrhage, produce an increase in portal pressure 
above the limit of the basal values in animals with high 
portal systemic shunting [26]. Additionally, a number 
of studies have shown that patients with alcoholic liver 
disease are known to have a variable and occasionally 
extensive degree of portosystemic shunting ranging 
from 5-70% [25, 26]. It must be mentioned that all pa-Int. J. Med. Sci. 2007, 4 
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tients’ medicines were always administrated with 
caution, especially those eliminated or modified 
through hepatic metabolism or biliary pathways. In 
particular, care was taken in order to avoid precipi-
tating complications of cirrhosis due to overzealous 
use of drugs such as vigorous treatment of ascites with 
diuretics that might result in electrolyte abnormalities 
or hypovolemia. Similarly, sedatives even in modest 
doses were not used in the patients; so that encepha-
lopathy observed in some patients studied herein, 
could not be attributed to such a use. 
5.  Conclusions 
In conclusion, in patients suffering from severe 
liver cirrhosis and ascites, portopulmonary shunt, in-
trapulmonary shunt and VA/Q inequality may induce 
a decrease in PaO2 and SaO2 in association with vari-
ous acid-base disturbances. As a result, pulmonary 
resistance is impaired and patients more likely suc-
cumb to infections and adult respiratory distress syn-
drome. Thus, prognosis in those patients is poor on the 
basis of both hepatic and pulmonary disease. 
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